CD4 and neoplasm: In PDAC, CD4+ T cells were found to promote differentiation of monocytes into MHC class II anti-tumor TAMs through cognate antigen recognition and downstream CD40 and IFN-γ pathways; in turn, these MHC class II TAMs are critical promoters of anti-tumor Th1 cells and anti-tumor immunity (76).